학술논문

Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM Patients Who Undergo ASCT: A107
Document Type
Academic Journal
Source
Clinical Lymphoma & Myeloma. Feb 01, 2009 9 Sup 1:S16-S17
Subject
Language
English
ISSN
1557-9190